Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Dianthus Therapeutics is a biotech company developing new treatments for serious autoimmune diseases using a more targeted approach.
Longeveron is a biotechnology company that focuses on developing cellular therapies for chronic aging-related and life-threatening diseases.
Solid Biosciences is a life science company that conducts research for the treatment of Duchenne muscular dystrophy.
Bicara Therapeutics develops dual-action cancer therapies, combining targeted treatments with tumor modulators for enhanced impact.
Immunic is a biopharmaceutical company that develops a pipeline of selective oral immunology therapies.
ILiAD is a clinical-stage biotechnology company focused on the prevention and treatment of disease caused by Bordetella Pertussis.
Galecto is a clinical stage biotechnology company focused on the development of novel treatments for fibrosis and cancer.
Angitia Biopharmaceuticals develops biologic therapies for musculoskeletal diseases.
Tenpoint Therapeutics is a biotechnology company pursuing vision-restoring engineered cell-based therapeutics.
Think Bioscience is reimagining synthetic biology by guiding the design and assembly of better medicines through the use of living systems.
Caldera Therapeutics is a biotech company engaged in the development of bispecific antibody CLD-423 for inflammatory bowel disease (IBD).
Diagonal Therapeutics is a biotechnology startup that develops targeted therapies for cancer and genetic diseases.
Phathom Pharmaceuticals is a biopharmaceutical company.
CAMP4 Therapeutics is a biotechnology company that uses RNA to restore healthy gene expression.
Athira Pharma is a clinical stage drug development company that specializes in biotechnology and pharmaceutical.
Yarrow is developing a first-in-class antibody targeting TSHR for the treatment of Graves’ disease and thyroid eye disease.
Ambros Therapeutics is a clinical-stage biotechnology company.
Kymera Therapeutics is a biotechnology company that specializes in the field of targeted protein degradation.
BlossomHill Therapeutics is a biopharmaceutical company focusing on oncology and autoimmune disorders.
Structure Therapeutics specializes in the discovery and development of drugs against a type of targets called GPCR.
Pasithea Therapeutics is a biotechnology company that seeks to solve clinical problems such as mental health.
Nuvalent is a biopharmaceutical company that develops targeted therapies for cancer by designing small-molecule medicines.
Centessa Pharmaceuticals is a pharmaceutical company that focuses on drug development to address significant medical needs.
Sonoma Biotherapeutics develops engineered regulatory T-cell (Treg) therapies to treat autoimmune and inflammatory diseases.
Janus Henderson Investors has invested in 229 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Janus Henderson Investors's top investment sectors include Biotechnology, Therapeutics, Health Care, Life Science, Medical. The firm invests across 14 different industry categories.
Among tracked funding rounds, Structure Therapeutics received $747.5M in a Post-IPO Equity round. Janus Henderson Investors's total known invested capital is $34.7B.
Janus Henderson Investors's average investment size is $151.4M across its portfolio of 229 companies.
Recent Janus Henderson Investors portfolio additions include Dianthus Therapeutics, Longeveron, Solid Biosciences, Bicara Therapeutics, Immunic Therapeutics. These companies were founded in 2020 or later.